Association of CTLA-4 Polymorphisms with Improved Overall Survival in Melanoma Patients Treated with CTLA-4 Blockade: A Pilot Study

By Queirolo P.  

Cancer Investigation, Vol. 31, Iss. 5, 2013-06 ,pp. : 336-345

Informa Healthcare

Access to resources Recommend Favorite

The Role of the CTLA4 Blockade in the Treatment of Malignant Melanoma

By Cranmer Lee   Hersh Evan  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 613-631

Informa Healthcare

Access to resources Recommend Favorite

Local secretion of anti-CTLA-4 enhances the therapeutic efficacy of a cancer immunotherapy with reduced evidence of systemic autoimmunity

By Simmons Andrew   Moskalenko Marina   Creson Jennifer   Fang Jianmin   Yi Saili   VanRoey Melinda   Allison James   Jooss Karin  

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 8, 2008-08 ,pp. : 1263-1270

Springer Publishing Company

Access to resources Recommend Favorite

Association of CTLA4 gene polymorphism (rs5742909) with cervical cancer: a meta-analysis

By Xu Hong-Bing   Yang Huan   Liu Tingting   Chen Hong  

Tumor Biology, Vol. 35, Iss. 2, 2014-02 ,pp. : 1605-1608

Springer Publishing Company

Access to resources Recommend Favorite

Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells

By                    

Oncology Reports, Vol. 33, Iss. 6, 2015-01 ,pp. : 2947-2953

Spandidos Publications

Access to resources Recommend Favorite